A cutting-edge RNA research facility promised to New South Wales more than four years ago will open its doors by next summer, delivering first-of-its-kind vaccine research and manufacturing capability...
A $2 billion government investment to bring Moderna to Australia is paying dividends before a vaccine has rolled off its Melbourne production line, according to the US pharmaceutical giant,...
A new working group will be convened by the federal Industry department to connect and promote Australia’s emerging RNA sector and make it a bigger part of a $158...
Melbourne venture capital firm Brandon Capital on Tuesday announced the first close of its sixth fund, which raised $270 million for local and global BioTechs. It takes the 2007...
MTPConnect, the industry growth centre set up to champion the Australian medtech sector will match $1m of funding for Covid19 related research efforts. The third round of its Biomedical...